Pulse Biosciences
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $264 | $86 | $0 | $832 |
Gross Profit | -255 | -193 | -267 | -283 |
EBITDA | -17,174 | -19,129 | -18,901 | -17,761 |
EBIT | -17,433 | -19,385 | -19,168 | -18,044 |
Net Income | -17,433 | -19,385 | -19,168 | -16,795 |
Net Change In Cash | 264 | 86 | 0 | 832 |
Free Cash Flow | -14,860 | -13,101 | -12,910 | -13,566 |
Cash | 80,735 | 95,214 | 106,349 | 119,279 |
Basic Shares | 67,395 | 67,385 | 67,276 | 67,126 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $350 | $0 | $-9 | $700 |
Gross Profit | -1,260 | -1,178 | -1,207 | -11,244 |
EBITDA | -71,710 | -55,079 | -42,367 | -56,702 |
EBIT | -72,781 | -56,257 | -43,574 | -58,057 |
Net Income | -72,781 | -53,585 | -42,210 | -58,953 |
Net Change In Cash | 350 | 0 | -9 | 700 |
Free Cash Flow | -54,437 | -36,468 | -33,162 | -47,414 |
Cash | 80,735 | 118,038 | 44,365 | 61,139 |
Basic Shares | 67,395 | 58,398 | 48,038 | 33,935 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-12-31 | -$0.25 |
2025-09-30 | -$0.29 |
2025-06-30 | -$0.28 |
2025-03-31 | -$0.25 |
